"name","text","description","id","label","uuid:ID","instanceType"
"OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","Objective_1","","f49b6fc6-fac3-4ce2-a77f-61b769dc1400","OBJECTIVE"
"OBJ2","To document the safety profile of the xanomeline TTS.","Safety","Objective_2","","1043d539-b20d-4f67-9acf-9ed48625ad87","OBJECTIVE"
"OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","Objective_3","","c1be3e3f-0f41-4df9-a8cf-543c0e914ad5","OBJECTIVE"
